21 May 2013
Keywords: gsk, merck, co, new, drugs, drive, antidepressant
Article | 04 July 2005
GlaxoSmithKline's triple reuptake inhibitor NS-2359 will be the first such class of drug to market, launching in 2009 and growing steadily ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 July 2005
© 2013 thepharmaletter.com